Evidence map›Paper›PMID 16926408›Full record

ArticleInfection and immunity2006

Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi.

Jason B Harris, Andrea Baresch-Bernal, Sean M Rollins, Ashfaqul Alam, Regina C LaRocque, Margaret Bikowski, Amanda F Peppercorn, Martin Handfield, Jeffery D Hillman, Firdausi Qadri and 5 more

Abstract read
In one paragraph

Article in Infection and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Functional role of the biofilm regulator CsgD inFrontiers in cellular and infection microbiology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  11. A review ofVeterinary world · 2019
    Review
  12. Article
  13. Article
  14. Identification of a NovelMolecular & cellular proteomics : MCP · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jason B HarrisDivision of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. jbharris@partners.org
Andrea Baresch-Bernal
Sean M Rollins
Ashfaqul Alam
Regina C LaRocque
Margaret Bikowski
Amanda F Peppercorn
Martin Handfield
Jeffery D Hillman
Firdausi Qadri
Stephen B Calderwood
Elizabeth Hohmann
Robert F Breiman
W Abdullah Brooks
Edward T Ryan

Funding

Treatments for Nipah Virus InfectionU54AI057159 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KASPER, DENNIS L. · 2003 to 2013
$113.7M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
Mucosal Immunity to Antigens Expressed by V.choleraeR01AI040725 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 1997 to 2006
$2.5M
IN VIVO INDUCED ANTIGEN TECHNOLOGY OF AA IN LJPR01DE013523 · NIDCR · UNIVERSITY OF FLORIDA · PI HANDFIELD, MARTIN · 2000 to 2003
$990k
The role of TcpA in cholera immunity and vaccinationK01TW007409 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2005 to 2011
$867k
Identification of human gene polymorphisms related to Vibrio cholerae infectionK01TW007144 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI LAROCQUE, REGINA C · 2004 to 2009
$617k
FIC NIH HHS K01 TW007144FIC NIH HHS K01 TW007409FIC NIH HHS K01 TW 07144FIC NIH HHS K01 TW 07409NIAID NIH HHS AI 40725NIAID NIH HHS R01 AI040725NIAID NIH HHS T32 AI007061NIAID NIH HHS T32 AI 07061NIAID NIH HHS U01 AI058935NIAID NIH HHS U01 AI 58935NIAID NIH HHS U54 AI 057159NIAID NIH HHS U54 AI057159NICHD NIH HHS K12 HD000850NICHD NIH HHS K12 HD 00850NIDCR NIH HHS R01 DE013523NIDCR NIH HHS R01 DE 13523
6 · The paper itself

Abstract

We applied an immunoscreening technique, in vivo-induced antigen technology (IVIAT), to identify immunogenic bacterial proteins expressed during human infection with Salmonella enterica serovar Typhi, the cause of typhoid fever. We were able to assign a functional classification to 25 of 35 proteins identified by IVIAT. Of these 25, the majority represent proteins with known or potential roles in the pathogenesis of S. enterica. These include proteins implicated in fimbrial structure and biogenesis, antimicrobial resistance, heavy metal transport, bacterial adhesion, and extracytoplasmic substrate trafficking as well as secreted hydrolases. The 10 remaining antigens represent proteins with unknown functions. Of the 35 identified antigens, four had no immunoreactivity when probed with control sera from individuals never exposed to serovar Typhi organisms; these four included PagC, TcfB, and two antigens of unknown function encoded by STY0860 and STY3683. PagC is a virulence factor known to be upregulated in vivo in S. enterica serovar Typhimurium infection of mice. TcfB is the major structural subunit of a fimbrial operon found in serovar Typhi with no homolog in serovar Typhimurium organisms. By examining differential immunoreactivities in acute- versus convalescent-phase human serum samples, we found specific anti-PagC and anti-TcfB immunoglobulin G responses in patients with serovar Typhi bacteremia. Serovar Typhi antigens identified by IVIAT warrant further evaluation for their contributions to pathogenesis, and they may have diagnostic, therapeutic, or preventive uses.

Indexed as

Antigens, BacterialBacterial ProteinsHumansImmunoassayImmunoglobulin GMembrane ProteinsSalmonella typhiTyphoid FeverAntigens, BacterialBacterial ProteinsImmunoglobulin GMembrane Proteins

Identifiers

PMID16926408
PMCPMC1594849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.